Target Price | CHF233.50 |
Price | CHF177.20 |
Potential |
31.77%
register free of charge
|
Number of Estimates | 2 |
2 Analysts have issued a price target HBM Healthcare Investments 2026 .
The average HBM Healthcare Investments target price is CHF233.50.
This is
31.77%
register free of charge
CHF236.00
33.18%
register free of charge
CHF231.00
30.36%
register free of charge
|
|
A rating was issued by 2 analysts: 2 Analysts recommend HBM Healthcare Investments to buy, 0 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the HBM Healthcare Investments stock has an average upside potential 2026 of
31.77%
register free of charge
|
Mar '25 |
2026 Estimates |
|
---|---|---|
Revenue Million CHF | 42.01 | 132.30 |
81.16% | 214.93% | |
Net Margin | 44.13% | 77.78% |
1,047.62% | 76.24% |
1 Analyst has issued a sales forecast HBM Healthcare Investments 2026 . The average HBM Healthcare Investments sales estimate is
This results in the following potential growth metrics:
1 Analyst has issued a net profit forecast HBM Healthcare Investments 2026 . The average HBM Healthcare Investments net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Mar '25 |
2026 Estimates |
|
---|---|---|
Earnings Per Share CHF | 2.72 | 15.29 |
1,800.00% | 462.13% | |
P/E | 11.59 | |
EV/Sales | 9.74 |
1 Analysts have issued a HBM Healthcare Investments forecast for earnings per share. The average HBM Healthcare Investments EPS is
This results in the following potential growth metrics and future valuations:
HBM Healthcare Investments...
Analyst | Rating | Action | Date |
---|---|---|---|
BAADER HELVEA EQUITY RESEARCH |
Locked
➜
Locked
|
Locked | Jan 19 2025 |
BAADER HELVEA EQUITY RESEARCH |
Locked
➜
Locked
|
Locked | Oct 20 2024 |
Analyst Rating | Date |
---|---|
Locked
BAADER HELVEA EQUITY RESEARCH:
Locked
➜
Locked
|
Jan 19 2025 |
Locked
BAADER HELVEA EQUITY RESEARCH:
Locked
➜
Locked
|
Oct 20 2024 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.